Homocysteine and cognition in first-episode psychosis patients

European Archives of Psychiatry and Clinical Neuroscience

Volumn 262, Issue 7, 2012, Pages 557-564

  Ayesa Arriola, Rosa ^a,b   Pérez Iglesias, Rocío ^a,b   Rodríguez Sánchez, José Manuel ^a,b   Mata, Ignacio ^a,b   Gómez Ruiz, Elsa ^a   García Unzueta, Maite ^a   Martínez García, Obdulia ^a   Tabares Seisdedos, Rafael ^b,c   Vázquez Barquero, Jose L ^a,b   Crespo Facorro, Benedicto ^a,b  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Cognition; Homocysteine; Psychosis; Schizophrenia

Indexed keywords

HOMOCYSTEINE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PROGNOSIS; PSYCHOLOGIC ASSESSMENT; PSYCHOSIS; SCHIZOPHRENIA;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; COGNITION DISORDERS; FEMALE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RETROSPECTIVE STUDIES; SPAIN; YOUNG ADULT;

EID: 84868003490     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-012-0302-2     Document Type: Article

References (47)

1. Andreasen NC (1983) Scale for the assessment of negative symptoms (sans). University of Iowa, Iowa City
2. Andreasen NC (1984) Scale for the assessment of positive symptoms (saps). University of Iowa, Iowa City
3. Baron-Cohen S, Wheelwright S, Hill J, Raste Y, Plumb I (2001) The "reading the mind in the eyes" test revised version: a study with normal adults, and adults with Asperger syndrome or highfunctioning autism. J Child Psychol Psychiatry 42:241-251 (Pubitemid 32233124)
4. Brown AS, Bottiglieri T, Schaefer CA, Quesenberry CP Jr, Liu L, Bresnahan M, Susser ES (2007) Elevated prenatal homocysteine levels as a risk factor for schizophrenia. Arch Gen Psychiatry 64:31-39 (Pubitemid 46041736)
5. Carew TG, Lamar M, Cloud BS, Grossman M, Libon DJ (1997) Impairment in category fluency in ischemic vascular dementia. Neuropsychology 11:400-412 (Pubitemid 27294663)
6. Cegalis JBJ (1991) Vigil: Software for the assessment of attention. Forthought Nashua, NH, In
7. Cortese C, Motti C (2001) Mthfr gene polymorphism, homocysteine and cardiovascular disease. Public Health Nutr 4:493-497 (Pubitemid 32524571)
8. Crespo-Facorro B, Rodriguez-Sanchez JM, Perez-Iglesias R, Mata I, Ayesa R, Ramirez-Bonilla M, Martinez-Garcia O, Vazquez-Barquero JL (2009) Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison. J Clin Psychiatry 70:717-729
9. Dias VV, Brissos S, Cardoso C, Andreazza AC, Kapczinski F (2009) Serum homocysteine levels and cognitive functioning in euthymic bipolar patients. J Affect Disord 113:285-290
10. Dittmann S, Seemuller F, Grunze HC, Schwarz MJ, Zach J, Fast K, Born C, Dargel S, Engel RR, Bernhard B, Moller HJ, Riedel M, Severus WE (2008) The impact of homocysteine levels on cognition in euthymic bipolar patients: a cross-sectional study. J Clin Psychiatry 69:899-906 (Pubitemid 351944941)
11. Elias MF, Sullivan LM, D'Agostino RB, Elias PK, Jacques PF, Selhub J, Seshadri S, Au R, Beiser A, Wolf PA (2005) Homocysteine and cognitive performance in the Framingham offspring study: age is important. Am J Epidemiol 162:644-653 (Pubitemid 41437363)
12. Evans JJ, Chua SE, McKenna PJ, Wilson BA (1997) Assessment of the dysexecutive syndrome in schizophrenia. Psychol Med 27:635-646 (Pubitemid 27216189)
13. Galderisi S, Davidson M, Kahn RS, Mucci A, Boter H, Gheorghe MD, Rybakowski JK, Libiger J, Dollfus S, Lopez-Ibor JJ, Peuskens J, Hranov LG, Fleischhacker WW (2009) Correlates of cognitive impairment in first episode schizophrenia: the EUFEST study. Schizophr Res 115:104-114
14. Goff DC, Bottiglieri T, Arning E, Shih V, Freudenreich O, Evins AE, Henderson DC, Baer L, Coyle J (2004) Folate, homocysteine, and negative symptoms in schizophrenia. Am J Psychiatry 161:1705-1708 (Pubitemid 39201472)
15. Golden CJ (1975) A group version of the Stroop Color and Word Test. J Pers Assess 39:386-388
16. Gonzalez-Blanch C, Crespo-Facorro B, Alvarez-Jimenez M, Rodriguez-Sanchez JM, Pelayo-Teran JM, Perez-Iglesias R, Vazquez-Barquero JL (2007) Cognitive dimensions in first-episode schizophrenia spectrum disorders. J Psychiatr Res 41:968-977 (Pubitemid 47259090)
17. Green MF (1996) What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153:321-330 (Pubitemid 26074706)
18. Harvey PD (2009) When does cognitive decline occur in the period prior to the first episode of schizophrenia? Psychiatry (Edgmont) 6:12-14
19. Johnson JL, Ratner PA, Malchy LA, Okoli CT, Procyshyn RM, Bottorff JL, Groening M, Schultz A, Osborne M (2010) Genderspecific profiles of tobacco use among non-institutionalized people with serious mental illness. BMC Psychiatry 10:101
20. Kale A, Naphade N, Sapkale S, Kamaraju M, Pillai A, Joshi S, Mahadik S (2010) Reduced folic acid, vitamin B12 and docosahexaenoic acid and increased homocysteine and cortisol in nevermedicated schizophrenia patients: Implications for altered onecarbon metabolism. Psychiatr Res 175:47-53
21. Levine J, Agam G, Sela BA, Garver DL, Torrey EF, Belmaker RH (2005) Csf homocysteine is not elevated in schizophrenia. J Neural Transm 112:297-302 (Pubitemid 40179121)
22. Levine J, Stahl Z, Sela BA, Gavendo S, Ruderman V, Belmaker RH (2002) Elevated homocysteine levels in young male patients with schizophrenia. Am J Psychiatry 159:1790-1792
23. Levine J, Stahl Z, Sela BA, Ruderman V, Shumaico O, Babushkin I, Osher Y, Bersudsky Y, Belmaker RH (2006) Homocysteine-reducing strategies improve symptoms in chronic schizophrenic patients with hyperhomocysteinemia. Biol Psychiatry 60:265-269 (Pubitemid 44093437)
24. Lezak M (1995) Neuropsychological assessment. Oxford University Press, N.Y.
25. Ma YY, Shek CC, Wong MC, Yip KC, Ng RM, Nguyen DG, Poon TK (2009) Homocysteine level in schizophrenia patients. Aust N Z J Psychiatry 43:760-765
26. Martin-Fernandez JJ, Carles-Dies R, Canizares F, Parra S, Aviles F, Villegas I, Morsi-Hassan O, Fernandez-Barreiro A, Herrero MT (2010) homocysteine and cognitive impairment in Parkinson's disease. Rev Neurol 50:145-151
27. Muntjewerff JW, Hoogendoorn ML, Kahn RS, Sinke RJ, Den Heijer M, Kluijtmans LA, Blom HJ (2005) Hyperhomocysteinemia, methylenetetrahydrofolate reductase 677tt genotype, and the risk for schizophrenia: a Dutch population based case-control study. Am J Med Genet B Neuropsychiatr Genet 135B:69-72 (Pubitemid 40577858)
28. Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK (2004) Identification of separable cognitive factors in schizophrenia. Schizophr Res 72:29-39 (Pubitemid 39452903)
29. O'Donnell C, Stephens T (2005) The significance of homocysteine levels in schizophrenia. Am J Psychiatry 162:1387-1388 author reply 1388-1389
30. Obeid R, McCaddon A, Herrmann W (2007) The role of hyperhomocysteinemia and b-vitamin deficiency in neurological and psychiatric diseases. Clin Chem Lab Med 45:1590-1606 (Pubitemid 350232981)
31. Osterrieth PA (1944) Contribution a l'étude de la perception et de la memoire (the test of copying a complex figure: a contribution to the study of perception and memory). Archive de Psychologie 30:286-350
32. Oulhaj A, Refsum H, Beaumont H, Williams J, King E, Jacoby R, Smith AD (2010) Homocysteine as a predictor of cognitive decline in Alzheimer's disease. Int J Geriatr Psychiatry 25:82-90
33. Pelayo-Teran JM, Perez-Iglesias R, Ramirez-Bonilla ML, Gonzalez-Blanch C, Martinez-Garcia O, Pardo-Garcia G, Rodriguez-Sanchez J, Roiz-Santianez R, Tordesillas-Gutierrez D, Mata I, Vazquez-Barquero JL, Crespo-Facorro B (2008) Epidemiological factors associated with treated incidence of first-episode non-affective psychosis in cantabria: insights from the clinical programme on early phases of psychosis. Early Interv Psychiatry 2:178-187
34. Petronijevic ND, Radonjic NV, Ivkovic MD, Marinkovic D, Piperski VD, Duricic BM, Paunovic VR (2008) Plasma homocysteine levels in young male patients in the exacerbation and remission phase of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 32:1921-1926
35. Reif A, Schneider MF, Kamolz S, Pfuhlmann B (2003) Homocysteinemia in psychiatric disorders: association with dementia and depression, but not schizophrenia in female patients. J Neural Transm 110:1401-1411 (Pubitemid 38041346)
36. Reitan RM, Wolfson D (1985) The Halstead-Reitan neuropsychological test battery: Therapy and clinical interpretation. Neuropsychological Press, Tucson
37. Rethelyi JM, Czobor P, Polgar P, Mersich B, Balint S, Jekkel E, Magyar K, Meszaros A, Fabian A, Bitter I (2011) General and domain-specific neurocognitive impairments in deficit and nondeficit schizophrenia. Eur Arch Psychiatry Clin Neurosci [Epub ahead of print]
38. Rey A (1964) L'examen clinique en psychologie. Presses Universitaires de France, Paris
39. Russo C, Morabito F, Luise F, Piromalli A, Battaglia L, Vinci A, Trapani Lombardo V, de Marco V, Morabito P, Condino F, Quattrone A, Aguglia U (2008) Hyperhomocysteinemia is associated with cognitive impairment in multiple sclerosis. J Neurol 255:64-69
40. Segarra R, Ojeda N, Zabala A, Garcia J, Catalan A, Eguiluz JI, Gutierrez M (2011) Similarities in early course among men and women with a first episode of schizophrenia and schizophreniform disorder. Eur Arch Psychiatry Clin Neurosci [Epub ahead of print]
41. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PW, Wolf PA (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 346:476-483 (Pubitemid 34441738)
42. Shallice T (1982) Specific impairments of planning. Philos Trans R Soc Lond B Biol Sci 298:199-209
43. Spreen OSE (1990) A compendium of neuropsychological tests. Oxford University Press, New York
44. Stahl Z, Belmaker RH, Friger M, Levine J (2005) Nutritional and life style determinants of plasma homocysteine in schizophrenia patients. Eur Neuropsychopharmacol 15:291-295 (Pubitemid 40487732)
45. Susser E, Brown AS, Klonowski E, Allen RH, Lindenbaum J (1998) Schizophrenia and impaired homocysteine metabolism: a possible association. Biol Psychiatry 44:141-143 (Pubitemid 28305534)
46. Vogel T, Dali-Youcef N, Kaltenbach G, Andres E (2009) Homocysteine, vitamin b12, folate and cognitive functions: a systematic and critical review of the literature. Int J Clin Pract 63:1061-1067
47. Wechsler D (1997) Wechsler adult intelligence scale, 3rd edn. The Psychological Corporation, San Antonio